• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

TUHURA BIOSCIENCES, INC.

Notes

No. Proposition For Against Abstain
1

To amend the Articles of Incorporation, as amended, of TuHURA to increase the number of authorized shares of TuHURA Common Stock from 75 million shares to 200 million shares (the Authorized Share Increase Proposal).

2

To approve the reincorporation of TuHURA from Nevada to Delaware (the Delaware Conversion Proposal).

3

DIRECTOR James A Bianco, M.D.

4

DIRECTOR James Manuso, Ph.D.

5

DIRECTOR Alan List, M.D

6

DIRECTOR George Ng

7

DIRECTOR Robert Hoffman

8

DIRECTOR Craig Tendler, M.D.

9

To approve, on a non-binding advisory basis, the compensation for our named executive officers (the Executive Compensation Proposal).

10

To ratify the appointment of Cherry Bekaert LLP as TuHURAs independent registered public accounting firm for fiscal year ending December 31, 2025 (the Auditor Ratification Proposal).

11

The TuHURA Adjournment Proposal, presented for approval at the special meeting, would permit the adjournment of the meeting if necessary to gather additional proxies in the event insufficient shares are represented to achieve a majority vote on Authorized Share Increase Proposal, to meet quorum requirements, to provide updates or amendments to the joint proxy statement/prospectus to stockholders, or to ensure compliance with applicable laws, thereby allowing for the postponement of the meeting as needed to fulfill all business and legal obligations.